Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …

Convalescent plasma (CP) from blood donors with antibodies to severe acute respiratory
syndrome coronavirus 2 may benefit patients with COVID-19 by providing immediate …

Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …

Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …

Editorial The transfer of immunity from a protected to an infected host dates back to the end
of the XIXth century, on both experimental and clinical grounds. Perhaps the pioneer large …

Dear Editor, we would like to share ideas on †œLocally harvested Covid-19 convalescent
plasma could probably help combat the geographically determined SARS-CoV-2 viral …

BACKGROUND: Amidst the raging coronavirus disease-2019 (COVID-19 pandemic),
COVID-19 convalescent plasma (CCP) therapy emerged as an important experimental …

We would like to use the opportunity to discuss some of the safety concerns of convalescent
COVID-19 plasma, raised by Mungmunpuntipantip and Wiwanitkit in their letter [1]. We …

Abstract COVID-19, 2019 yılında Çin'de ortaya çıkmış ve kısa sürede tüm dünyayı etkileyen
bir salgın haline gelmiştir. Enfekte kişiler asemptomatikten kritik hastalığa kadar çeşitli klinik …

Background: Understanding demographics and collection characteristics of Convalescent
Plasma (CP) donors is the corner stone for maintaining a viable inventory of high titre CP …